Abstract
Introduction
The occurrence of pneumocystis pneumonia in patient with collagen disease on immunosuppressive therapy is not uncommon. But only a few case reports are available about this infection in active untreated collagen disorders. She was evaluated for the cause of breathlessness. Urine & blood culture was sterile. Sputum examination did not show acid fast bacilli. Chest X-ray revealed bilateral diffuse infiltrate, more in perihilar regions.CT scan of chest shows bilateral diffuse infiltrate, more in perihilar regions, nodular densities. Echocardiography shows mild pericardial effusion, EF 67%, pulmonary arterial pressure 45mmHg. ECG shows normal findings. Laboratory report reveals Hb-11.2g/ dl,WBC-9500/cumm with 93% neutrophil, 06% lymphocytes, and 1% monocytes, ESR120mm in 1 st hour and platelet count 3,00,000, Alanine aminotransferase 15U/L,S.ceatinine 1.06 mg/dl. First sputum for pneumocystis jerovecii shows negative but induced sputum by 3%NaCl shows pneumocystis jerovecii by Giemsa stain done at Clinical Pathology Department of BSMMU (Fig A, B) .
Discussion
Pulmonary manifestations of connective tissue diseases are a diagnostic challenge to the clinicians. It could be disease related due to immune mediate insult, vasculities, pulmonary hemorrhage, and pulmonary hypertension or caused by infection. Opportunistic infections with organism like pneumocystis jerovecii frequently complicate immunosuppressive status. 1 The mechanism of immune suppression in patients with SLE who have PCP is usually multi-factorial, 2 and may be related to underlying diseases, cytotoxic therapies, or Fig.-1 (A)   Fig.-1 (B)   Fig.-1(A & B) : Sputum smear stained with Giemsa stain shows Pneumocystis jerovecii (oil immersion). malnutrition. However, the development of PCP in most patients with SLE is associated with daily administration of corticosteroids and with the development of lymphopenia. 3 Corticosteroids cause immunosuppression mainly by sequestration of CD4+T-lymphocytes in the reticuloendothelial system and by inhibiting the transcription of cytokines. [4] [5] Corticosteroid therapy is a rare but possible independent predisposition to Pneumocystis jirovecii infection. [6] [7] Prolonged corticosteroid therapy is characterised by a significant immunological dysfunction.
In this case patient was treated by cyclosporin with prednisolone and she was also lymphopenic, may decrease CD4 count. 8 This impairs cellular immunity and predispose to opportunistic infection like pneumocystis jerovecii. The diagnosis of PCP was made by sputum analysis in our case. The sensitivity of the sputum analysis is 50-60%, though less sensitive, 9 sputum examination is highly specific for organism. 10 
Conclusion
Pneumocystis pneumonia is a fatal disease.Pneumocystis pneumonia occurs mostly mmunocompromised patient. The patient response well to the anti pneumocystis treatment. The clinicians should be aware that, at some point of time immunosuppressed patients can present with concurrent infections with Pneumocystis jirovecii.
